Legend Biotech (LEGN) Current Leases (2019 - 2025)
Legend Biotech (LEGN) posted Current Leases of $7.4 million for Q4 2025, little changed on a QoQ basis from $7.4 million in Q3 2025, and up 54.17% year-over-year from $4.8 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Current Leases data on file, last reported at $7.4 million in Q4 2025.
- In Q4 2025, Current Leases rose 54.17% year-over-year to $7.4 million; the TTM figure through Dec 2025 stood at $7.4 million (up 54.17% YoY), while the FY2025 annual figure was $7.4 million, up 54.17% from the prior year.
- Current Leases held at $7.4 million in Q4 2025, from $7.4 million in the prior quarter.
- Across five years, Current Leases topped out at $7.4 million in Q4 2025 and bottomed at $1621.0 in Q2 2021.
- A 5-year average of $3.7 million and a median of $3.6 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases slumped 37.77% — and 2022, when it surged 218070.95%.
- Year by year, Current Leases stood at $911000.0 in 2021, then soared by 291.11% to $3.6 million in 2022, then decreased by 10.89% to $3.2 million in 2023, then soared by 51.18% to $4.8 million in 2024, then soared by 54.17% to $7.4 million in 2025.
- The last three Current Leases figures came in at $7.4 million (Q4 2025), $7.4 million (Q3 2025), and $5.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 16.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 5.91 Mn |
| Mar 31, 2025 | 5.34 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 3.12 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 3.56 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Dec 31, 2021 | 911,000.00 |
| Sep 30, 2021 | 1.87 Mn |
| Jun 30, 2021 | 1,621.00 |
| Mar 31, 2021 | 1,673.00 |
| Dec 31, 2020 | 1.46 Mn |
| Sep 30, 2020 | 2,543.00 |
| Jun 30, 2020 | 2,119.00 |
| Dec 31, 2019 | 1.03 Mn |